PRESENTATION

ON
CIPLA PHARMACEUTICAL
LTD.

Submitted to:- Submitted by:-

Mr. Harsimranjeet Singh Pooja
Chauhan
Lec, DBIMCS B.B.A(3rd)
R.No-8
Headquarters of Cipla in Mumbai,Maharashtra
 COMPANY PROFILE
• TYPE:- Public
• INDUSTRY:- Pharmaceutical
• FOUNDED:- 1935
• HEADQUARTERS:- Mumbai, Maharashtra
• KEY PEOPLE:- Y. K. Hamid (CMD) Chairman
• PRODUCTS:- Pharmaceuticals & Diagnostics
• REVENUE:- Rs.6977.50 million(US $ 1.1 billion)
(2012)
• EMPLOYEES:- Over 16,000
• WEBSITE:- www.cipla.com
Cipla Pharmaceutical Pvt. Ltd is one of South
Africa’s fastest growing pharmaceutical companies
and currently third largest cipla is a leading provider
of chronic medicines to the public and private
sectors. It commands an ever-increasing share
within, Inter alia, the cardiovascular, respiratory
categories. Headquartered in cape town, with
regional offices throughout the country, Cipla is
listed on the Johannesburg Securities Exchange(JSE)
through holding company cipla medpro south africa
ltd. Cipla received the Thomson Reuters India
Innovation Award in 2012.
 PRODUCTS WHICH ARE
EXPORTED BY CIPLA
Manufacturers of pharmaceutical bulk drugs, finished
formulations, natural medicines, herbal medicines etc.
LIST OF PRODUCTS
Products offered:-
Animal health care products
Antibiotics
Antiseptics
Aqua products
Equine products
Finished formulations
 Pharmaceutical bulk drugs
 Herbal anti-obesity powder for drugs
 Herbal medicines
 Natural medicines
 Products for livestock animals
Founded prior to Indian independence by Hamid on
the principle that India needed to become self-
sufficient in supplying medicine to its people, cipla
has emphasized self-reliance and the right of all
people to health and access to medicine, regardless
of their economic circumstances or where in the
world they happen to live. Cipla co-opertaes with
other enterprises in areas such as consulting,
commissioning, engineering, project appraisal,
quality control and plant supply.
 DIRECTORS REPORT

The Directors take pleasure in presenting the 76th

annual report of the company along with the
audited account for the financial year ended 31st
march 2012. In this, it included the gross total
revenue, profit before or after tax, dividend, tax on
dividend and other terms of cipla company.
YEAR ENDED 31ST MAR,11 FINANCIAL TERMS YEAR ENDED 31ST MAR,12
(Rs.in CR)

6490 Gross total revenue 7223

1151 Profit before tax 1421

960 Profit after tax 1.124

1699 Surplus brought forward from 2298

last balance sheet
2659 Profit available for 3422
appropriation
64 Appropriations interim ---
dividend
160 Dividend 160

37 Tax on dividend 26

100 Transfer to general reserve 125

2298 Surplus carried forward 3111

TOTAL INCOME & PROFIT AFTER TAX
CIPLA & ITS COMPIETITORS
 COUNTRIES WHERE CIPLA
EXPORTED THEIR PRODUCTS
Export markets include the US, Canada, Latin
America, Europe, Australia and West Asia. Cipla has
traditionally adopted a partnership model to sell its
drugs in the overseas markets. But now, the
company is mulling a shift in its export strategy. It
have a global presence in over 170 countries
through exports & strategic alliances. Our exports
include raw materials, intermediates, prescription
drugs, OTC & veterinary products.
THANK YOU……